CJC-1295 with DAC
CD2
Lyophilized peptide for use under a licensed healthcare provider. Choose single ampule/vial or box of 10. Sourced via Ares Technology Limited (Hong Kong) / Healthtide Biotech manufacturing list dated 7 October 2026. Specification: 2 mg × 10 vials.
- • Prescription / clinician-supervised pathway
- • Same LIRAVEXIN cart and checkout as pen packages
- • Not medical advice — individual suitability is determined by your clinician
Clinical reference (clinician-supervised)
Clinical research demonstrated multi-day GH and IGF-1 elevation after intermittent dosing in healthy adults. Wellness clinic use remains off-label/investigational relative to approved GH therapies.
Published healthy-adult research used approximately 30–60 mcg/kg SC in single or repeated doses (e.g., weekly/biweekly patterns in studies). Exact clinic translation requires specialist judgment—do not equate vial mg to a DIY weekly dose.
Intermittent (study-dependent; often multi-day intervals).
Subcutaneous.
Typical clinical / literature ranges under clinician supervision — not a prescription and not a DIY dosing guide. Individual dosing is determined solely by the treating clinician.
Liravexin USD for this pack (wholesale comparison · source × 3). Item is added to your shared cart for checkout coordination with your clinician pathway.
Or continue to checkout →